Laplace Interventional
PrivateLast Round
Series C
Mar 16, 2025
Total Funding Raised
$42.8M
Company Overview
Laplace Interventional operates in Healthcare & Life Sciences and is based in Plymouth, Minnesota. Its latest recorded funding round was a Series C round in March 2025.
Laplace Interventional is a medical device company developing a minimally invasive transcatheter tricuspid valve replacement system to treat tricuspid regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Laplace Interventional Comparables
Compare Laplace Interventional with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VDyne | 93% | |
| Versa Vascular, Inc. | 92% | |
| Trisol Medical | 91% |
For institutional investors. Book with your work email.
Laplace Interventional Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 16, 2025 | ||||
| Series B | Jul 24, 2023 | ||||
| Series A | Sep 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Laplace Interventional Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aphelion Capital | Series C |
| Features Capital | Series C, Series B |
| Unorthodox Ventures | Series C |
| Alpha JWC Ventures | Series B |
| J.W.C. Venture Capital | Series C |
| Mayo Clinic Ventures | Series A |
| ShangBay Capital | Series A, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 14, 2025
Grew 20% QoQ, from 15 to 18 employees.
- Jun 8, 2025
Grew 21% QoQ from 14 to 17 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 29, 2026
Laplace Interventional Inc. is developing a prosthetic valve to treat Tricuspid Regurgitation through a minimally invasive procedure via a vein in the neck or groin, with the device studied in the prospective, multicenter TRIUMPH pivotal IDE trial.
For institutional investors. Book with your work email.
Laplace Interventional Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Laplace Interventional's valuation, stock price, and market status.
Is Laplace Interventional a public or private company?
Laplace Interventional is a private company.
What is the current stock price of Laplace Interventional?
Laplace Interventional is a private company, so its shares have no public market price. Caplight tracks Laplace Interventional's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Laplace Interventional worth (valuation)?
Valuation information for Laplace Interventional is not publicly available.
Can I buy Laplace Interventional stock?
Laplace Interventional shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Laplace Interventional's last funding round?
Laplace Interventional's most recent funding round was Series C on March 16, 2025.
Who are the main investors in Laplace Interventional?
Key investors in Laplace Interventional include Features Capital, ShangBay Capital.
Will Laplace Interventional IPO soon?
No public IPO plans have been announced for Laplace Interventional.
How can I track Laplace Interventional secondary market activity?
Caplight tracks bids, offers, and trades in Laplace Interventional's shares on secondary markets.